ISAP / EPASG 2025 Annual Meeting - From Coffee to Dinner

Anti-Infective PK/PD

 Advancing Science and Collaboration
from Coffee to Dinner

Vienna, Austria

10^th April 2025

In cooperation with

Preliminary Program

09.00-10.00             ISAP Business Meeting (ISAP members only)

10.00-10.20             Registration for joint ISAP/EPASG meeting, coffee/tea

10.20-11.20             Plenary talk: Past, present and future of antimicrobial pharmacology –
                                        How can we combat the AMR Crisis
                                       Prof. Alasdair MacGowan (Consultant in Infection Research/Professor of Antimicrobial Therapeutics at North Bristol NHS Trust/Univ. of Bristol, UK)

11.20-12.20             Topic area I:  Innovative treatment strategies

11.20-11.35             Unraveling Phage Pharmacodynamics Against KPC-5 Pseudomonas in the Hollow Fiber Infection Model
                                      Thomas D. Nguyen et al., SUNY Buffalo, Buffalo, NY, USA

11.35-11.50             Efficacy of ganciclovir against CMV infection is dependent on treatment initiation time
                                      Lalitya M. Sudarsono et al., Leiden University, Leiden, The Netherlands

11.50-12.05             Assessing the Therapeutic Potential of an Apramycin-Gallium Combination for Treating Acinetobacter baumannii Lung Infections
                                       Anissa Benkhaled et al., Université de Poitiers, Poitiers, France

12.05-12.20             Model-based evaluation of an optimised meropenem dosing strategy in the intensive care unit
                                       Nada Dia et al., KU Leuven, Leuven, Belgium

12.20-13.20             Lunch break

13.20-14.05             Bridging mechanistic research and clinical microbiology
                                       Dr. Bartolome Moya (Balearic Islands Health Research Institute [IdISBa], Palma de Mallorca, Spain)

14.05-15.20             Topic area II:  Antimicrobial PK/PD – Novel non-clinical findings

 14.05-14.20             Dual AmpC and AmpD mutations in Pseudomonas aeruginosa: Unraveling the Mechanisms of Resistance to Ceftazidime and Avibactam
                                        Albane Rozenholc et al., Université de Poitiers, Poitiers, France

14.20-14.35             Pharmacokinetic/pharmacodynamic modelling of immune response and meropenem activity in immunocompetent and neutropenic mouse lung infection models
                                       Raphaël Saporta et al., Uppsala University, Uppsala, Sweden

14.35-14.50             Multifunctional Antimicrobial Peptide: A Promising Therapeutic for Cancer, Bacterial Infections, and Immune Modulation
                                       Lukas Petrowitsch et al., University of Graz, Graz, Austria

14.50-15.05             A launching pad for next-generation therapeutics: Exploring mechanisms and biological profiles of novel OP-145 antimicrobial peptides
                                       Altea Topciu and Nermina Malanovic, University of Graz, Graz, Austria

15.05-15.20             No time to waste: hospital-wide assessment of IV- vial and line residuals and impact on target attainment
                                       Dorian Vanneste et al., KU Leuven, Leuven, Belgium

15.20-15.45             Coffee/tea break

15.45-16.30             How to optimize patient outcomes – PK/PD to support clinical dosing
                                      Prof. Elisabet Nielsen (Uppsala University, Sweden)

16.30-18.00             Topic area III:  Antimicrobial PK/PD: Novel clinical findings 

16.30-16.45             Application of dried blood spot sampling for therapeutic drug monitoring of vancomycin and creatinine in the Outpatient Parenteral Antimicrobial Therapy service: a                                               qualitative analysis of facilitators and barriers
                                       Moska Hassanzai et al., Erasmus MC University Medical Centre – Rotterdam, The Netherlands

16.45-17.00             Ten years of susceptibility testing of linezolid in a tertiary care hospital: model-informed precision dosing as a strategy for rising resistance
                                      Johannes Starp et al., LMU University Hospital, LMU Munich, Germany

17.00-17.15             Colistin population pharmacokinetic modelling and pharmacodynamic target attainment in critically-ill patients on with sustained low-efficiency dialysis
                                     Dominika Fuhs et al., Monash University, Parkville, VIC, Australia

17.15-17.30             Isavuconazole pharmacokinetics in critically ill patients with acute-on-chronic liver failure and continuous hemodialysis: An observational study
                                     Emily Behrens et al., University of Hamburg, Hamburg, Germany

17.30-17.45             Old friends, new foes: Explorative assessment of the potential drug-drug interaction between metamizole and mold-active azoles
                                     Dorian Vanneste, KU Leuven, Leuven, Belgium

17.45-18.00            Enhanced Clearance of Broadly Neutralizing HIV-1 Antibody VRC07-523-LS Under Viremia: Influences on Trial Design and Analysis
                                     Brian Ho et al., SUNY Buffalo, Buffalo, NY, USA

18.00-18.15             Trainee award ceremony

18.15-19.00             Travel to dinner venue – 10er Marie (oldest ‘Heuriger’ in Vienna)

19.30                          Networking dinner

Organising Committee on behalf of ISAP and EPASG

Markus Zeitlinger*                           Jürgen Bulitta*                          (*conference chairs)
Iris Minichmayr                                 Alina Nussbaumer-Pröll
Sebastian Wicha                              Cornelia Landersdorfer
Lena Friberg                                       Zachary Bulman

Registration

The registration fees include lunch, coffee breaks and dinner (refunding registration fee is not possible)

Venue: Van Swieten Hall at the Medical University of Vienna

To register, please visit the Annual Meeting page on the ISAP homepage:

• https://www.isap.org/index.php/meetings/isap-epasg-annual-meeting

Abstract submission for young investigators

Submission deadline: February 28, 2025

Abstract format: ECCMID abstract format template (Word or pdf file):
(see https://www.escmid.org/congress-events/escmid-global/abstracts/guidelines-templates)

Send to: This email address is being protected from spambots. You need JavaScript enabled to view it.

Please indicate in your email which topic area I, II, or III the abstract belongs to (also see above:
I. Innovative treatment modalities, II. Novel non-clinical findings or III. Novel clinical findings)

Venue

Van Swieten Hall, Medical University of Vienna

Van-Swieten-Gasse 1a
1090 Wien

Welcome!